MedMen Enterprises Inc. MMNFF's fiscal third-quarter results saw increased revenue by 22 percent to $36.6 million across operations in California, Nevada, New York, Arizona and Illinois.
MedMen continued to perform favorably in California with $24.9 million in retail revenue and retail gross margins increasing to 57 percent.
MedMen reported its revenue from pending acquisitions and pre-closing revenue from recently closed acquisitions, pro forma quarterly revenue was approximately $57 million.
MedMen decreased corporate selling, general and administrative expense by 9 percent quarter over quarter with a plan to achieve an overall 20 percent reduction from the previous quarter. The company also announced a $250 million financing commitment from Gotham Green Partners.
MedMen's stock traded around $2.37 per share at time of publication.
Related Links:
Cresco Labs Reports Q1 Sales Of $21.1M, Up 313% Year Over Year
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!